Profile data is unavailable for this security.
Mergers & acquisitions
Acquired company | BMY:NYQ since announced | Transaction value |
---|---|---|
RayzeBio Inc | -18.13% | 4.21bn |
Karuna Therapeutics Inc | -16.48% | 14.40bn |
LianBio-Mavacamten Greater China Rights | -23.55% | 350.00m |
Mirati Therapeutics Inc | -24.44% | 5.12bn |
Data delayed at least 15 minutes, as of Jul 22 2024 17:11 BST.